Yayın:
What is the adequacy of biopsies for prostate sampling?

dc.contributor.buuauthorDoǧan, Hasan Serkan
dc.contributor.buuauthorAytaç, Berna
dc.contributor.buuauthorKordan, Yakup
dc.contributor.buuauthorGasanov, Feyzullah
dc.contributor.buuauthorYavaşçaoǧlu, İsmet
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPatoloji Ana Bilim Dalı
dc.contributor.departmentÜroloji Ana Bilim Dalı
dc.contributor.researcheridAAH-9746-2021
dc.contributor.researcheridABH-5513-2020
dc.contributor.scopusid7005856022
dc.contributor.scopusid56527372000
dc.contributor.scopusid9633365800
dc.contributor.scopusid56629254000
dc.contributor.scopusid6603612497
dc.date.accessioned2022-01-25T12:09:40Z
dc.date.available2022-01-25T12:09:40Z
dc.date.issued2011
dc.description.abstractObjective: To investigate the adequacy of the samples obtained by prostate biopsies and the factors those could affect this adequacy. Materials and methods: Three hundred seventy-eight patients who underwent transrectal ultrasound guided biopsy have been included into the study. The biopsy samples have been retrospectively reviewed in terms of presence of prostatic glandular elements and prostatic tissue. Factors which may affect the presence of glandular elements have been investigated. Results: The mean age, PSA level, and prostate volume were 65 +/- 8.1 years, 13.6 +/- 17.8 ng/ml, and 52.5 +/- 29.8 ml, respectively. Overall cancer detection rate was 25.3%. The highest incidence of absence of prostatic glandular elements was detected at apical (21.8%) and far lateral (21.5%) biopsy samples. The overall rate of absence of glandular elements was 0.16. Absence of glandular elements in at least 1 sample of the biopsy set was detected in 50% of patients. This figure was 27.8% and 16.1% for the absence of glands in at least 3 and 5 samples of the biopsy set, respectively. These results have also been found to be operator-dependent. For patients with PSA between 4 and 10 ng/ml, we found that cancer detection rate was lower in patients with absence of glandular elements. When the possible factors were analyzed, age, PSA, prostate volume, findings of prostate examination, and presence of cancer were not found to be effective on these parameters, whereas the most important factor was the biopsy localization. Conclusion: Our study showed that prostatic glandular elements, which are keys for histological diagnosis, were absent in a significant number of prostatic biopsy samples and patients. This inadequacy was most prominent in apical and far lateral biopsy specimens and found to be operator-dependent.
dc.identifier.citationDoǧan, H. S. vd. (2011). ''What is the adequacy of biopsies for prostate sampling?''. Urologic Oncology-Seminars and Original Investigations, 29(3), 280-283.
dc.identifier.doi10.1016/j.urolonc.2009.03.014
dc.identifier.endpage283
dc.identifier.issn1078-1439
dc.identifier.issue3
dc.identifier.pubmed19450999
dc.identifier.scopus2-s2.0-79955769192
dc.identifier.startpage280
dc.identifier.urihttps://doi.org/10.1016/j.urolonc.2009.03.014
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S107814390900088X
dc.identifier.urihttp://hdl.handle.net/11452/24291
dc.identifier.volume29
dc.identifier.wos000290779400010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.journalUrologic Oncology-Seminars and Original Investigations
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectUrology & nephrology
dc.subjectBiopsy
dc.subjectCancer
dc.subjectDiagnosis
dc.subjectGlandular coverage
dc.subjectPathology
dc.subjectProstate
dc.subjectEnd-cut technique
dc.subjectLong-core needle
dc.subjectCancer detection
dc.subjectTissue
dc.subjectGland
dc.subject.emtreeProstate specific antigen
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeBiopsy localization
dc.subject.emtreeCancer diagnosis
dc.subject.emtreeExocrine gland
dc.subject.emtreeGroups by age
dc.subject.emtreeHistopathology
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeOrgan size
dc.subject.emtreePriority journal
dc.subject.emtreeProstate biopsy
dc.subject.emtreeProstate cancer
dc.subject.emtreeProtein blood level
dc.subject.emtreeRetrospective study
dc.subject.emtreeSampling
dc.subject.emtreeSampling adequacy
dc.subject.emtreeTissue distribution
dc.subject.emtreeTransrectal ultrasonography
dc.subject.meshAged
dc.subject.meshBiopsy, needle
dc.subject.meshEndosonography
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshPrognosis
dc.subject.meshProstate
dc.subject.meshProstate-specific antigen
dc.subject.meshProstatic neoplasms
dc.subject.scopusDigital Rectal Examination; Prostate; Gleason Score
dc.subject.wosOncology
dc.subject.wosUrology & nephrology
dc.titleWhat is the adequacy of biopsies for prostate sampling?
dc.typeArticle
dc.wos.quartileQ2 (Oncology)
dc.wos.quartileQ1 (Urology & nephrology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Üroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Patoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama